Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways

Background: The introduction of effective novel biomarkers of invasion and metastasis is integral for the advancement of breast cancer management. The present study focused on the identification and evaluation of calreticulin (CRT) as a potential biomarker for breast cancer invasion. Methods: Two-di...

Full description

Bibliographic Details
Published in:Cancer Cell International
Main Author: Zamanian M.; Qader Hamadneh L.A.; Veerakumarasivam A.; Abdul Rahman S.; Shohaimi S.; Rosli R.
Format: Article
Language:English
Published: BioMed Central Ltd. 2016
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979695866&doi=10.1186%2fs12935-016-0329-y&partnerID=40&md5=0a488b522fda931809b93dc3eb5bfb5b

Similar Items